R717 (Lamotrigine Extended-Release 25 mg)
Pill with imprint R717 is Yellow, Round and has been identified as Lamotrigine Extended-Release 25 mg. It is supplied by Dr. Reddy's Laboratories, Inc..
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R717
Lamotrigine Extended-Release
- Imprint
- R717
- Strength
- 25 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories, Inc.
- National Drug Code (NDC)
- 55111-0717
Related Images for "R717"
More about lamotrigine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1365 Reviews
- Drug class: triazine anticonvulsants
- FDA Alerts (6)
Consumer resources
- Patient Information
- Lamotrigine (Advanced Reading)
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Other brands
- Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.